Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD)

Clinical trial NCT00095433 · COMPLETED

Trial details

NCT number: NCT00095433
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Macular Degeneration

Start date: 2002-09-01
Primary completion: 2006-08-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.